Which structural feature best distinguishes azithromycin from erythromycin among the macrolide antibiotics?

Explanation

## Structural Differentiation of Macrolides ### Azithromycin vs Erythromycin: Key Structural Difference **Key Point:** Azithromycin is classified as an **azalide** — a subclass of macrolides defined by the insertion of a methyl-substituted nitrogen atom into the lactone ring, which **expands the ring from 14 members (erythromycin) to 15 members (azithromycin)**. The single best distinguishing structural feature is therefore the **15-membered lactone ring** compared to erythromycin's 14-membered ring. ### Macrolide Ring Systems | Feature | Erythromycin | Azithromycin | Clarithromycin | |---------|--------------|--------------|----------------| | Lactone ring size | 14-membered | **15-membered** | 14-membered | | Ring composition | C–O backbone | C–N–C backbone (nitrogen insertion) | C–O backbone | | Unique structural element | Classical macrolide | Azalide (N-methyl nitrogen in ring) | 6-O-methyl group at C-6 | | Acid stability | Poor | Excellent | Moderate | **High-Yield:** The defining structural feature that **best distinguishes** azithromycin from erythromycin is the **15-membered lactone ring** (vs. 14-membered in erythromycin). This ring expansion results from the insertion of a methyl-substituted nitrogen atom between C-9 and C-10 of the erythromycin backbone — a modification that simultaneously creates the azalide class and expands the ring size. ### Why Option A is Correct and Option B is Incomplete - **Option A (15-membered ring):** This is the net, observable structural outcome that definitively distinguishes azithromycin from erythromycin. Ring size is the primary classification criterion used in pharmacology texts (KD Tripathi, Goodman & Gilman). - **Option B (methyl-substituted nitrogen):** While the nitrogen insertion is the *mechanism* by which the ring expands, it is not an independent feature — it is the *cause* of the 15-membered ring. Moreover, the nitrogen is part of the ring itself; stating it as a separate feature from the ring size is redundant and potentially misleading. The ring size (15 vs. 14) is the single best distinguishing structural descriptor per standard pharmacology references. ### Clinical Pearl The 15-membered azalide ring confers azithromycin's pharmacokinetic advantages: - **Superior acid stability** → reliable oral bioavailability - **High lipophilicity** → excellent intracellular penetration (macrophages, respiratory epithelium) - **Long tissue half-life** → once-daily dosing and short 3–5 day courses - **Reduced GI motility side effects** compared to erythromycin **Mnemonic: AZI-15** — Azithromycin = **AZ**alide with a **15**-membered ring. [cite: KD Tripathi, Essentials of Medical Pharmacology, 8th ed., Ch. 46; Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th ed., Ch. 56]